OPTIMIZING DIAGNOSTIC ACCURACY IN CUSHING SYNDROME USING 1 MG DEXAMETHASONE SUPPRESSION TEST CUT-OFFS

D S Yaman Kalender1, Mehmet Çalan2, Seçil Özışık3

  • 1Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir.

Acta Endocrinologica (Bucharest, Romania : 2005)
|October 10, 2025
PubMed
Summary

Optimized cut-off values for the 1 mg dexamethasone suppression test (DST) improve Cushing Syndrome (CS) diagnosis. New thresholds enhance accuracy for differentiating CS subtypes, aiding timely treatment.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.9K
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
471
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
830